Home » News » Page 356

Category

News

Country Spotlight: China 

With strong headline figures, China remains an exciting possibility for daring foreign companies. James Harris reports

News

News

When experience matters

A new investment scheme could provide vital managerial expertise and capital to fledgling businesses. James Harris reports

News

Boomerang buys Indus

Boomerang Plus, a Cardiff-based television production group, has acquired local rival Indus Films for £1.1 million in cash.

News

SMEs see recession’s silver lining

Most small and medium-sized enterprises are seeing some benefits to the current econonic climate, according to a survey from the ICAEW.

News

First Derivatives increases stake in Kx

First Derivatives has upped its stake in US group Kx Systems after lifting interim profits 36 per cent to £3.1 million.

News

Ultra acquires Scytale

Middlesex-based Ultra Electronics has acquired US software company Scytale for up to $7.3 million (£4.5 million).

News

Ludgate tops up agri.capital stake

News

Lease-backed securities spurned by QE programme

None of the £175 billion created by the quantitative easing programme has been used to buy lease-backed securities, claims finance provider Syscap. 

News

Ludgate tops up agri.capital stake

News

Lease-backed securities spurned by QE programme

None of the £175 billion created by the quantitative easing programme has been used to buy lease-backed securities, claims finance provider Syscap. 

News

Annual reports get more chatty

Companies are becoming more communicative in their annual reports, according to a study from accountancy firm Deloitte.

News

LSL Property acquires HEAL 

LSL Property Services has acquired Halifax Estate Agencies (HEAL), which operates an estate agency network across the UK, from Lloyds Banking Group for a nominal sum.

News

US firm in Huntingdon Life Science deal

News

Sinclair Pharma in Solvay deal

Oral health and dermatology specialist Sinclair Pharma is raising £25 million and buying two products from Belgium’s Solvay Pharmaceuticals.

Recommended Content